A New Study Recommends Diabetes Mellitus Drugs Could Slow Alzheimer’s Progression
The research found a link between slower cognitive decline and diabetic patients taking drugs called gliptins. Credit: Wavebreakmedia/Depositphotos A brand-new study released in the journal Neurology reports an association between a particular substance class to deal with type 2 diabetes and lowered Alzheimer's disease biomarkers. It is unclear exactly just how these diabetes mellitus medicines...